Viveve Medical, Inc. (VIVE)

Viveve Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-23.92	-22.82	-21.24	-46.72	-49.18	-36.63
Depreciation & Amortization	0.81	1.14	1.3	1.18	0.79	0.45
Share-Based Compensation	3.75	3.78	2.65	2.4	0	1.87
Other Operating Activities	3.13	5.03	2.06	11.9	5.31	-0.54
Operating Cash Flow	-16.23	-12.88	-15.23	-31.24	-43.09	-34.85
Capital Expenditures	-0.6	-0.46	-0.78	-1.09	-2.14	-0.91
Other Investing Activities	-	-	-	-	-	-2.5
Investing Cash Flow	-0.6	-0.46	-0.78	-1.09	-2.14	-3.41
Dividends Paid	-4.69	0	0	0	0	0
Common Stock Issued	-24.53	25.83	0.34	16.27	53.79	31.64
Share Repurchases	0.72	0.7	0.34	0.06	0.23	0.08
Other Financing Activities	30	0.85	9.23	-0.11	0.47	19.34
Financing Cash Flow	0.07	25.97	9.23	16.11	54.03	50.9
Net Cash Flow	-16.76	12.64	-6.79	-16.22	8.79	12.64
Free Cash Flow	-16.83	-13.33	-16.02	-32.32	-45.23	-35.76
Free Cash Flow Margin	-246.51%	-207.50%	-292.30%	-492.20%	-244.27%	-233.90%
Free Cash Flow Per Share	-1.58	-1.32	-10.18	-259.03	-1456.33	-2043.78

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.